Financials
Financial year 2025
NEPHROQUIN from Spa, company number BE0721598242, closed financial year 2025 with a result of € 108,172 after tax. For that financial year NEPHROQUIN recorded a gross margin of € 167,738 and equity of € 327,980. Compared with financial year 2024, the result moved from € 79,664 to € 108,172. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.
€ 327,980
▲ 17% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 108,172
▲ 36% vs 2024
Profit after tax over the fiscal year.
€ 339,814
▲ 7% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 60,000 paid out
55 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 49,015
▼ 24% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 24,301
▼ 54% vs 2024
Loans from banks and other lenders, long and short.
€ 896
▼ 67% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 42,400
▲ 57% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 194,427 | - | - | - | |
| Gross margin | € 79,750 | € 91,469 | € 125,059 | € 167,738 | ▲ 34% |
| Profit after taxes | € 59,465 | € 59,734 | € 79,664 | € 108,172 | ▲ 36% |
| Equity | € 200,410 | € 260,144 | € 279,808 | € 327,980 | ▲ 17% |
| Total debts | € 41,510 | € 107,146 | € 142,055 | € 127,598 | ▼ 10% |
| Cash | € 194,307 | € 208,101 | € 319,071 | € 339,814 | ▲ 7% |
| Retained profit | € 180,810 | € 240,544 | € 260,208 | € 308,380 | ▲ 19% |
| Dividend | € 40,000 | € 0 | € 60,000 | € 60,000 | |
| Bank debt | € 0 | € 79,297 | € 52,371 | € 24,301 | ▼ 54% |
| Balance sheet total | € 241,920 | € 367,290 | € 421,864 | € 455,578 | ▲ 8% |
Key figures of NEPHROQUIN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to NEPHROQUIN?
What happened at NEPHROQUIN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Bérengère MONVILLE stepped down as director. NBB
- Kévin QUINONEZ stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 108,172 (▲ 36% vs 2024). Source: NBB ↗
- New establishment in Spa. KBO
- Bérengère MONVILLE became a director. NBB
- Kévin QUINONEZ became a director. NBB
- New establishment in Spa. KBO
- Start of the company according to the CBE. KBO
In short
From € 59,465 profit in 2022 to € 108,172 profit in 2025.
Paid € 100,168 in corporate taxes since 2022.
Best year ever: 2025, with € 108,172 profit.
Paid out € 160,000 in dividends to the owners in total.
Management
Directors
According to the 2025 annual accounts
Bérengère MONVILLE
Director
since 2021 · until 2027
Kévin QUINONEZ
Director
since 2021 · until 2027
Establishments
Establishment units
Physical locations of this company
Rue des Ecomines 32 box 1
4900 Spa
Avenue Reine Astrid 54
4900 Spa
Active since 1 October 2021
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0721.598.242
- VAT number
- BE 0721.598.242
- Registered office
- Rue des Ecomines 32 bus 1, 4900 Spa
- Names & denominations
- NEPHROQUIN
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 26 February 2019
- Peppol
- Active · Active since 21 Mar 2025
- Activities · NACE
Activiteiten van huisartspraktijken
Activiteiten van medisch specialisten